Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2005;58:263-268; doi:10.1136/jcp.2004.018606
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2005;58:263-268
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas

J Haapasalo1, A Mennander2, P Helen3, H Haapasalo and J Isola4

1 University of Turku, Turku, FIN-20520, Finland
2 Heart Centre, Tampere University Hospital, Tampere, Finland
3 Department of Neurosurgery, Tampere University Hospital
4 Institute of Medical Technology, University of Tampere, Tampere, FIN-33014, Finland

Correspondence to:
Correspondence to:
Dr H Haapasalo
Department of Pathology, Tampere University Hospital, PO Box 2000, FIN-33521 Tampere, Finland; hannu.haapasalo{at}pshp.fi

Background: Astrocytic tumours, the most common gliomas, are often classified intraoperatively using standard morphological staining. The final diagnosis and grading of gliomas on paraffin wax sections is often assisted by Ki-67 immunohistochemistry, but standard immunostaining protocols take too long to be used intraoperatively.

Aims: To investigate a new rapid Ki-67 immunohistochemical test for its use in an intraoperative setting.

Methods: The new Ki-67 immunostaining (Ultrarapid-Ki67®) method on frozen sections can be carried out in 10 minutes. Thirty four pilocytic and diffuse astrocytomas were immunostained by rapid Ki-67 and results were compared with corresponding MIB-1 staining, histological grading, and prognosis.

Results: The staining protocol was practical to perform and the results were morphologically and quantitatively indistinguishable from those after immunostaining with MIB-1, an antibody recognising Ki-67 in paraffin wax embedded tissue. A comparison of Ultrarapid-Ki67 and MIB-1 immunostaining of paraffin wax sections showed almost identical quantitative correlation in astrocytic gliomas (r = 0.916; p<0.001). The Ultrarapid-Ki67 indices (percentage of positive cells) of low grade (I/II) astrocytomas ranged from 0% to 6.1%, whereas those of representative high grade (III/IV) tumours were significantly higher (range, 5.6–45%; p<0.001). The best prognostic cutoff point for Ultrarapid-Ki67 was 7.5%, which divided diffuse grade II–IV astrocytomas into significantly differing subsets (p = 0.0008).

Conclusion: Ultrarapid-Ki67 immunostaining is a useful adjunct to morphological diagnosis and grading of astrocytic tumours, and as a fast test (~10 minutes for staining plus three to four minutes for scoring), it could be used in routine intraoperative diagnosis of gliomas and other neoplastic diseases.

Abbreviations: DAB, diaminobenzidine; HE, haematoxylin and eosin; IHC, immunohistochemistry; ROC, receiver operating characteristics; WHO, World Health Organisation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs